Narrative Update • May 05
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedMay 09, 2026
DataAggregated Company Financials
Companies9
- 7D0.2%
- 3M-15.2%
- 1Y10.6%
- YTD-4.6%
In the last week, Pharma has been flat. The past year has been better, since the industry has gained 11% in that time. Earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 09 May 2026 | €88.4b | €67.9b | -€888,696,183.51 | 18x | -99.4x | 1.3x |
| Mon, 06 Apr 2026 | €89.9b | €67.9b | -€900,262,286.16 | 20.1x | -99.9x | 1.3x |
| Wed, 04 Mar 2026 | €93.1b | €68.3b | €2.9b | 17.7x | 32.5x | 1.4x |
| Fri, 30 Jan 2026 | €100.4b | €68.3b | €2.9b | 17.4x | 35.1x | 1.5x |
| Sun, 28 Dec 2025 | €90.6b | €68.3b | €2.9b | 17.8x | 31.6x | 1.3x |
| Tue, 25 Nov 2025 | €82.1b | €68.5b | €2.9b | 16.6x | 28.5x | 1.2x |
| Thu, 23 Oct 2025 | €80.1b | €68.8b | -€439,049,980.15 | 19.6x | -182.5x | 1.2x |
| Sat, 20 Sep 2025 | €77.1b | €68.8b | -€438,183,950.69 | 17.3x | -175.9x | 1.1x |
| Mon, 18 Aug 2025 | €78.3b | €68.9b | -€409,975,346.15 | 17x | -191.1x | 1.1x |
| Wed, 16 Jul 2025 | €77.1b | €69.4b | -€283,071,598.00 | 17.5x | -272.4x | 1.1x |
| Fri, 13 Jun 2025 | €80.5b | €69.4b | -€206,268,848.00 | 18.2x | -390.3x | 1.2x |
| Sun, 11 May 2025 | €80.0b | €69.3b | €463.8m | 19x | 172.5x | 1.2x |
| Tue, 08 Apr 2025 | €71.0b | €69.3b | €467.0m | 17.3x | 151.9x | 1x |
| Thu, 06 Mar 2025 | €86.4b | €69.2b | €2.0b | 22.1x | 42.6x | 1.2x |
| Sat, 01 Feb 2025 | €87.7b | €69.2b | €2.0b | 23.6x | 43.2x | 1.3x |
| Mon, 30 Dec 2024 | €82.4b | €69.2b | €2.0b | 22.6x | 41x | 1.2x |
| Wed, 27 Nov 2024 | €82.8b | €69.2b | €2.0b | 22.1x | 40.9x | 1.2x |
| Fri, 25 Oct 2024 | €95.2b | €69.4b | €1.6b | 20.4x | 61x | 1.4x |
| Sun, 22 Sep 2024 | €99.3b | €69.4b | €1.5b | 24x | 68x | 1.4x |
| Tue, 20 Aug 2024 | €104.8b | €69.3b | €1.5b | 31x | 71.9x | 1.5x |
| Thu, 18 Jul 2024 | €95.9b | €69.2b | -€303,627,757.00 | 29.3x | -315.8x | 1.4x |
| Sat, 15 Jun 2024 | €103.9b | €69.2b | -€328,028,608.00 | 22.6x | -316.9x | 1.5x |
| Mon, 13 May 2024 | €98.6b | €70.0b | -€71,355,764.97 | 20.3x | -1382x | 1.4x |
| Wed, 10 Apr 2024 | €96.1b | €70.0b | -€34,208,180.00 | 21x | -2808.4x | 1.4x |
| Fri, 08 Mar 2024 | €96.6b | €70.0b | €6.2m | 19.9x | 15596.7x | 1.4x |
| Sun, 04 Feb 2024 | €94.9b | €70.6b | -€647,396,793.00 | 22.1x | -146.6x | 1.3x |
| Tue, 02 Jan 2024 | €98.5b | €70.6b | -€650,504,143.00 | 19.8x | -151.4x | 1.4x |
| Thu, 30 Nov 2023 | €102.6b | €70.6b | -€651,446,256.00 | 19.7x | -157.4x | 1.5x |
| Sat, 28 Oct 2023 | €104.5b | €72.1b | €4.7b | 17.6x | 22.3x | 1.4x |
| Mon, 25 Sep 2023 | €118.7b | €72.1b | €4.7b | 21x | 25.4x | 1.6x |
| Wed, 23 Aug 2023 | €121.2b | €72.1b | €4.7b | 22.3x | 26x | 1.7x |
| Fri, 21 Jul 2023 | €120.2b | €74.1b | €6.5b | 18.6x | 18.6x | 1.6x |
| Sun, 18 Jun 2023 | €126.9b | €74.1b | €6.4b | 22.3x | 19.8x | 1.7x |
| Tue, 16 May 2023 | €127.2b | €74.0b | €6.4b | 22.1x | 20x | 1.7x |
Price to Earnings Ratio
20x
Current Industry PE
- Investors are relatively neutral on the German Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 2.9% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.016% | |
| Healthcare | -0.79% | |
| Pharma | 0.19% | |
| Pharma | 0.19% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck KGaA | €112.85 | 2.5% +€1.2b | -8.5% | PE18.8x | |
| HIGH Cantourage Group | €6.20 | 7.6% +€5.5m | 28.1% | PS39.6x | |
| 93M1 MPH Health Care | €20.80 | 3.5% +€3.0m | -12.2% | PB0.4x | |
| 27N0 Cannovum Cannabis | €0.38 | 4.7% +€39.3k | 53.4% | n/a |